Product
Supplier
Encyclopedia
Inquiry
Imatinib buy - large image1
Imatinib buy - image1

Imatinib

3 Inquiries

Unit Price:

$1/MT FOB

Get Latest Price
CAS No.:

152459-95-5

Grade:

Pharmaceutical Grade

Content:

99%

Port:

SHANGHAI

Packaging:

25kg/2.5kg Fiber Drum

Price valid (until):

2095-06-30

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Imatinib mesylate

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Imatinib is an oral medication used to treat chronic, accelerated and chronic phase of failure of interferon treatment in adults with chronic myelogenous leukemia (CML) in Philadelphia chromosomes (Ber-Abl) . CML is a hematopoietic stem cell disorder caused by abnormal DNA of stem cells in the bone marrow. Abnormal DNA can produce abnormal protein, interfere with the normal process of bone marrow white blood cells, eventually leading to a sharp increase in the number of white blood cells. CML is divided into chronic phase, accelerated phase and crisis phase of three stages, the crisis of patients with an average survival of only 2-3 months between elbows. Imatinib is an oral medication used to treat chronic, accelerated and chronic phase of failure of interferon treatment in adults with chronic myelogenous leukemia (CML) in Philadelphia chromosomes (Ber-Abl) . CML is a hematopoietic stem cell disorder caused by abnormal DNA of stem cells in the bone marrow. Abnormal DNA can produce abnormal protein, interfere with the normal process of bone marrow white blood cells, eventually leading to a sharp increase in the number of white blood cells. CML is divided into chronic phase, accelerated phase and crisis phase of three stages, the crisis of patients with an average survival of only 2-3 months between elbows.

    English name: Imatinib

    CAS No : 152459-95-5

    Molecular formula: C29H31N7O

    Molecular weight: 493.6


    Basic Info
    Product Name:

    Imatinib

    Other Name:

    Benzamide,4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-;4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide;CGP 57148;Imatinib;4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide;Genfatinib;N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide

    CAS No.:

    152459-95-5

    Molecular Formula:

    C29H31N7O

    InChIKeys:

    InChIKey=KTUFNOKKBVMGRW-UHFFFAOYSA-N

    Molecular Weight:

    493.6

    Exact Mass:

    493.60

    EC Number:

    1308068-626-2

    UNII:

    BKJ8M8G5HI

    NSC Number:

    759854|743414

    DSSTox ID:

    DTXSID3037125

    NCI Thesaurus Code:

    C62035

    ATC Code:

    L01XE01|L - Antineoplastic and immunomodulating agents

    HScode:

    29339900

    Categories:

    Antineoplastic Agents

    Characteristics
    PSA:

    86.3

    XLogP3:

    3

    Appearance:

    Solid

    Density:

    1'+-.0.06 g/cm3(Predicted)

    Melting Point:

    208-209 °C @ Solvent: Dichloromethane, Hexane

    Boiling Point:

    754.9ºC at 760 mmHg

    Flash Point:

    410.3ºC

    Water Solubility:

    Very soluble in water at pH < 5.5 (mesylate salt)

    Storage Conditions:

    Refrigerator

    Vapor Pressure:

    6.03E-24mmHg at 25°C

    Collision Cross Section:

    214.6 Ų [M+H]+ [CCS Type: TW, Method: Major Mix IMS/Tof Calibration Kit (Waters)]

    Hazard Identification

    Classification of the substance or mixture

    Germ cell mutagenicity, Category 2

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 1B

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H341 Suspected of causing genetic defects

    H351 Suspected of causing cancer

    H360 May damage fertility or the unborn child

    H362 May cause harm to breast-fed children

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Imatinib mesylate

    Location:

    No.21,HuanCheng West Road ,AnQing City ,Anhui Province,China

    Payment Terms:

    D/P,L/C,D/A

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2009

    Certifications:

    business license,ISO9001

    ANHUI HAIKANG PHARMACEUTICAL CO.,LTD. was established in 2009 in Anqing City, Anhui Province. It is located along the north bank of mid and lower reaches of the Yangtze River. Enjoying favorable  geographic superiorities and convenient transportation infrastructure: such as highway, high speed railway, airport, inland shipping container terminal and so on. By plane, it takes just 1 hour to Shanghai, 2 hours to Guangzhou or Beijing; by high speed train it takes 2 hours to reach Nanjing, 4 hours to Shanghai, 6.5 hours Beijing.Since founded the company has been committed to the production, sales and export of chemical raw materials of pharmaceutical APIs and intermediates, while as well as other services of product customization, process improvement, achievement transfer,etc.

    The company covers an area of 28000 square meters. We invested 80 million Yuan to set up 3 synthesis workshops and 3 purification workshops, whose annual output value is over hundred million Yuan, and their profits and taxes are over 20 million Yuan. All our productions are in strict accordance with GMP standard and we have established a well-equipped R & D center.

    Haikang currently employs 50 people. 2 of them are of doctoral degree, 6 of master degree,1 researcher returned from overseas and all the rest employees have at least college education. We have close cooperation with Zhejiang University of Technology, University of Science and Technology of China and Anhui University of Chinese Medicine ,etc. We have an academic advisors team consisting of experts and professors who have well background of medical profession and ample experience in pharmacy developing and marketing. It is a united, hard-working, courageous, rigorous and innovative team of elites.

    Through years of unremitting efforts Haikang has made remarkable achievements in the R&D and production of anti-virus, antidiabetic series APIs and intermediates. The main products are ganciclovir, valganciclovir hydrochloride, valaciclovir HCL, silodosin, repaglinide, sitagliptin, imatinib and their intermediates. We have established long and stable relationship with nearly 100 domestic and international pharmaceutical manufacturers and research institutes.

    To deal with increasingly fierce competition and challenges of economic globalization, Haikang adheres to the business philosophy of “Customer is First, Technology is Leading, Quality is Everything, Honesty for Development” and insists on developing scientifically, globally and diversely. Relying on our existing advantages, we focus on the integration of various resources, and actively optimize the system of decision-making, management and service. We keep up with the pace of the newest R&D trend in and outside China; keep continuous innovation to develop high-tech, market prospective products to satisfy different needs from different customers. While pursuing economic benefits, Haikang has also committed to spare no efforts to advanced environmental management. It is always a mission and moreover a responsibility for Haikang to take care of people’s health and protect the environment.

    We have confidence in our future and looking forward to having sincere, win-win and brilliant cooperation with you!


  • Inquiry History
    3 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Imatinib

    100 G Oct 17, 2025
    Pakistan

    Imatinib

    1 KG Jul 23, 2025
    India

    Imatinib Methane Sulphate

    100 KG Jun 9, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.